Inflammation - A lifelong companion. Attempt at a non-analytical holistic view

Folia Microbiologica

Volumn 52, Issue 2, 2007, Pages 159-173

  Ferencik M ^a,b   Stvrtinova V ^a   Hulin I ^a   Novak M ^b  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMMUNICABLE DISEASE; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SIGNAL TRANSDUCTION;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; DIABETES MELLITUS, TYPE 2; GENOTYPE; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; NEOPLASMS; OBESITY; SIGNAL TRANSDUCTION;

EID: 34249930020     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02932155     Document Type: Article

References (81)

1. AKIRA S., UEMATSU S., TAKEUCHI O.: Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
2. AKYIAMA H., BARGER S., BARNUM S., BRADT B., BAUER J., COLE G.M., COOPER N.R., EIKELENBOOM P., EMMERLING M., FIEBICH B.L., FINCH C.E., FRAUTSCHY S., GRIFFIN W.S.T., HAMPEL H., HULL M., LANDRETH G., LIH- FEN LUE, MRAK R., MACKENZIE I.R., MCGEER P.L., O'BANION M.K., PACHTER J., PASINETTI G., PLATA-SALAMAN C., ROGERS J., RYDEL R., YONG SHEN, STREIT W., STROHMEYER R., TOOYOMA I., VAN MUISWINKEL F.L., VEERHUIS R., WALKER D., WEBSTER S., WEGRZYNIAK B., WENK G., WYSS-CORAY T.: Inflammation and Alzheimer's disease. Neurobiol.Aging 21, 383-421 (2000).
3. ANDREOTTI F., PORTO I., CREA F., MASERI A.: Inflammatory gene polymorphisms and ischemic heart disease: review of population association studies. Heart 87, 107-112 (2002).
4. ARENDT T.: Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 102, 723-765 (2001).
5. BOUCHON A., DIETRICH J., COLONNA M.: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J.Immunol. 164, 4991-4995 (2000).
6. BRUUNSGAARD H., PEDERSEN M., PEDERSEN B.K.: Aging and proinflammatory cytokines. Curr.Opin.Hematol. 131, 131-136 (2001).
7. BRUUNSGAARD H., LADELUND S., PEDERSEN A.N., SCHROLL M., JORGENSEN T., PETERSEN B.K.: Predicting death from necrosis factor-α and interleukin-6 in 80-year-old people. Clin.Exp.Immunol. 132, 24-31 (2003).
8. CALLE E.E., THUN M.J., PETRELLI J.M., RODRIGUEZ C., HEATH C.W. Jr.: Body-mass index and mortality in a prospective cohort of US adults. N.Engl.J.Med. 341, 1097-1105 (1999).
9. CARNEIRO L.A.M., TRAVASSOS L.H., PHILPOTT D.J.: Innate immune recognition of microbes through Nodi and Nod2: implications for disease. Microbes Infection 6, 609-616 (2004).
10. CARUSO C., LIO D., CAVALLONE L., FRANCESCHI C.: Ageing, longevity, inflammation, and cancer. Ann.N.Y.Acad.Sci. 1028, 1-13 (2004).
11. CHAMAILLARD M., GIRARDIN S.E., VIALA J., PHILPOTT D.J.: Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol. 5, 581-592 (2003).
12. CHENG C., DE CROM R., VAN HAPEREN R., HELDERMAN F., GOURABI B.M., VAN DAMME L.C.A., KIRSCHBAUM S.W., SLAGER C.J., VAN DER STEEN A.F.W., KRAMS R.: The role of shear stress in atherosclerosis - action through gene expression and inflammation. Cell Biochem.Biophys. 41, 279-295 (2004).
13. CURRAN J.E., JOWETT J.B.M., ELLIOT K.S., GAO Y., GLUSCHENKO K., WANG J., AZIM D.M.A., CAI G., MAHANEY M.C., COMUZZIE A.G., DYER T.D., EALDER K.R., ZIMMET P., MACCLUER J.W., COLLIER G.R., KISSEBAH A.H., BLANGERO J.: Genetic variation in selenoprotein S influences inflammatory response. Nature Genet, 37, 1234-1241 (2005).
14. DANDONA P., ALJADA A., BANDYOPADHYAY A.: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25, 4-7 (2004).
15. DAS U.: Metabolic syndrome X: an inflammatory condition? Curr.Hypertens.Rep. 6, 66-73 (2004).
16. ERLINGER T.P., PLATZ E.A., RIFAI N., HELZLSOUER K.J.: C-Reactive protein and the risk of incident colorectal cancer. JAMA 291, 585-590 (2004).
17. FERENČÍK M., EBRINGER L.: Modulatory effect of selenium and zinc on the immune system. Folia Microbiol. 48, 417-426 (2003).
18. FERENČÍK M., NOVÁK M., ROVENSKÝ J., RYBÁR I.: Alzheimer's disease, inflammation and non-steroidal antiinflammatory drugs. Bratislava Med.J. 102, 123-132 (2001).
19. FERENČÍK M., ŠTVRTFNOVÁ V., HULÍN I.: Defects in regulation of local immune responses resulting in atherosclerosis. Clin.Devehp. Immunol. 12, 225-234 (2005).
20. FRANCESCHI C., BONAFE M., VALENSIN S., OLIVIERI F., DE LUCA M., OTTAVIANI E., DE BENEDICTIS G.: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann.N. Y.Acad.Sci. 908, 208-218 (2000).
21. FROSTEGARD J.: Autoimmunity, oxidized LDL and cardiovascular disease. Autoimm.Rev. 1, 233-237 (2002).
22. GORDON S.: Pattern recognition receptors. Cell 111, 927-930 (2002).
23. GRAVES D.R., CHANNON K.M.: Inflammation and immune responses in atherosclerosis. Trends Immunol. 25, 535-541 (2002).
24. GREIWE J.S., CHENG B., RUBIN D.C., YARASHESKI K.E., SEMENKOVICH C.F.: Resistance exercise decreases skeletal muscle tumor necrosis factor a in frail elderly humans. FASEB J. 15, 475-482 (2001).
25. HAN J., ULEVITCH R.J.: Limiting inflammatory responses during activation of innate immunity. Nature Immunol. 6, 1182-1189 (2005).
26. HARGREAVES D.C., MEDZHITOV R.: Innate sensors of microbial infection. J.Clin.Immunol 25, 503-510 (2005).
27. HARRIS H.F., ANDERSSON U.: Mini-review: the nuclear HMGB1 as a proinflammatory mediator. Eur.J.Immunol. 34, 1503-1512 (2004).
28. HARRIS T.B., FERRUCCI T., TRACY R.P., CORTI M.C., WACHOLDER S., ETTINGER W.H. Jr., HEIMOVITZ H., COHEN H.J., WALLACE R.: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am.J.Med. 106, 506-512 (1999).
29. HENSON P.M.: Dampening inflammation. Nature Immunol. 6, 1179-1181 (2005).
30. HERRE J., GORDON S., BROWN G.D.: Dectin-1 and its role in the recognition of β-glucans by macrophages. Molec.Immunol. 40, 869-876 (2004).
31. HUSSAIN S.P., HOFSETH L.J., HARRIS C.C.: Radical causes of cancer. Nature Rev.Cancer 3, 276-285 (2003).
32. KEREIAKES D.J., WILLERSON J.T.: Metabolic syndrome epidemic. Circulation 108, 1552-1553 (2003).
33. KONSMAN J.P., PARNET P., DANTZER R.: Cytokine-induced sickness behavior: mechanisms and implications. Trends Neurosci. 25, 154-159 (2002).
34. KRABBE K.S., PEDERSEN M., BRUUNSGAARD H.: Inflammatory mediators in the elderly. Exp.Gerontol. 39, 687-699(2004).
35. LAZAR M.A.: How obesity causes diabetes: not a tall tale. Science 307, 373-375 (2005).
36. LEE Y.B., NAGAI A., KIM S.U.: Cytokines, chemokines, and cytokine receptors in human microglia. J.Neurosci.Res. 69, 94-103 (2002).
37. LIBBY P.: Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
38. LIBBY P., RIDGER P.M.: Inflammation and atherosclerosis: role of C-reactive protein in risk assesment. Am.J.Med. 116 (Suppl. 1), 9-16 (2004).
39. LICASTRO F.: Genomic and immune molecules: early detection of cognitive decline and new therapeutic interventions. Expert.Rev. Neurotherap. 2, 639-645 (2002).
40. LICASTRO F., PEDRINI S., CAPUTO L., ANNONI G., DAVIS L.J., FERRI C., CASADEI V., GRIMALDI L.M.: Increased plasma level of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation signals or signals from the brain? J.Neuroimmunol. 103, 97-102 (2000).
41. LICASTRO F., GRIMALDI L.M., BONAFE M., MARTINA C., OLIVIERI F.: Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol.Aging 24, 921-926 (2003).
42. LICASTRO F., CANDORE G., LIO D., PORCELLINI E., COLONNA-ROMANO G., FRANCESHI C., CARUSO C.: Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immunity Ageing 2, 8-23 (2005).
43. LOTZE M.T., TRACEY K.J.: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Rev. 5, 331-342 (2005).
44. MAEDA S.: Nod2 mutation in Crohn's disease potentiates NF-KB activity and IL-1β processing. Science 307, 734-738 (2004).
45. MARTINON F., BURNS K., TSCHOPP J.: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol.Cell 10, 417-426 (2002).
46. MC DERMOTT M.F., AKSENTIJEVICH I.: The antiinflammatory syndromes. Curr.Opin.Allergy Clin.Immunol. 2, 511-516 (2002).
47. MC GEER E.G., MC GEER P.L.: Innate immunity in Alzheimer's disease. Molec.Interventions 1, 22-29 (2001a).
48. MC GEER P.L., MC GEER E.G.: Polymorphisms in inflammatory genes and the risk of Alzheimer's disease. Arch.Neurol. 58, 1790-1792 (2001b).
49. MC GEER E.G., KLEGERIS A., MC GEER P.L.: Inflammation, the complement system and the disease of aging. Neurobiol.Aging 26, 94-97 (2005).
50. MEDZHITOV R., JANEWAY C. Jr.: Innate immunity. N.Engl.J.Med. 343, 338-344 (2000).
51. NOVÁK M.: Neuroimmunolgy of Alzheimer's disease, (In Slovak) Bratisl.Lek.Listy 98, 303-314 (1997).
52. PADAH S.: Periodic fever syndromes. Pediat.Clin.N.Am. 52, 577-609 (2005).
53. PAHL H.L., BAEUERLE P.A.: The ER-overload response: activation of NF-κB. Trends Biochem.Sci. 22, 63-67 (1997).
54. PEARSON T.A., MENSAH G.A., ALEXANDER R.W., ANDERSON J.K.L., CANNON R.O., CRIQUI M., FADL Y.Y., FORTMANN S.P., HONG Y., MYERS G.L., RIFAI N., SMITH S.C., TAUBERT K., TRACY R.P., VINICOR F.: Markers of inflammation and cardiovascular disease: application to clinical and public health practice - a statement for health care professionals from the Center for Disease Control and Prevention and the American Hearth Association. Circulation 107, 499-511 (2003).
55. PERRY V.H.: The influence of systemic inflammation on inflammation in the brains, implications for chronic neurodegenerative diseases. Brain Behav.Immun. 18, 407-413 (2004).
56. PLACKETT T.P., BOEHMER E.O., FAUNCE D.E., KOVACS E.J.: Ageing and innate immune cells. J.Leukoc.Biol. 76, 1-9 (2004).
57. POCKLEY A.G., WU R., LEMME C., KIESSLING R., DE FAIRE V., FROSTEGARD J.: Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 36, 303-307 (2000).
58. RENSHAW M., ROCKWELL J., ENGLEMAN C., GEWIRTZ A., KATZ J., SAMBHARA S.: Cutting edge: impaired Toll-like receptor expression and function in aging. J.Immunol 169, 4697-4701 (2002).
59. RIDGER P.M., MORROW D.A.: C-Reactive protein, inflammation, and coronary risk. Cardiol.Clin. 21, 315-325 (2003).
60. ROSS R.: Atherosclerosis: an inflammatory disease. N.Engl.J.Med. 340, 115-126 (1999).
61. ROUBENOFF R.: Catabolism of ageing: is it an inflammatory process? Curr.Opin.Clin.Nutr.Metab.Care 6, 295-299 (2003).
62. RUDIN E., BARZILAI N.: Inflammatory peptides derived from adipose tissue. Immunol.Ageing 2, 1-5 (2005).
63. SANDOR F., BUC M.: Toll-like receptors. I. Structure, function and their ligands. Folia Biol. 51, 148-156 (2005).
64. SELKOE D.J.: Alzheimer's disease: genes, proteins, and therapy. Physiol.Rev. 81, 741-766 (2001).
65. SENN J., KLOVER P., NOWAK I., MOONEY R.: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391-3399 (2002).
66. STEHLIK C., REED J.C.: The PYRIN connection: novel players in innate immunity and inflammation. J.Exp.Med. 200, 551-558 (2004).
67. STEPHENS J.W., HUMPHRIES S.E.: The molecular genetics of cardiovascular disease: clinical implications. J.Intern.Med. 253, 120-127 (2003).
68. STOJANOV S., KASTNER D.L.: Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr.Opin.Rheumatol. 17, 586-599 (2005).
69. STROBER W., MURRAY P.J., KITANI A., WATANABE T.: Signaling pathways and molecular interactions of NODI and NOD2. Nature Rev.Immunol. 6, 9-20 (2006).
70. SZLOSAREK P.W., BALKWILL F.R.: Tumor necrosis factor a: a potential target for the therapy of solid tumors. Lancet Oncol. 4, 565-573 (2003).
71. TAKEDA K., AKIRA S.: Toll-like receptors in innate immunity. Intern.Immunol. 17, 1-14 (2005).
72. TAKEDA K., KAISHO T., AKIRA S.: Toll-like receptors. Ann.Rev.Immunol. 21, 335-376 (2003).
73. THUN M.J., KENLEY S.J., GANSLER T.: Inflammation and cancer: an epidemiological perspective. Novartis Found.Symp. 256, 2-21 (2004).
74. TOWN T., NIKOLIC V., TAN J.: The microglial "activation" continuum: from innate to adaptive responses. J.Neuroinfl. 2, 24-32 (2005).
75. TSCHOPP J., MARTINON F., BURNS K.: NALPS: a novel protein family involved in inflammation. Nature Rev.Molec.Cell Biol. 4, 95-104 (2003).
76. TUPPO E.E., ARIAS H.R.: The role of inflammation in Alzheimer's disease. Internat.J.Biochem.Cell Biol. 73, 289-305 (2005).
77. VAN CRUCHTEN S., VAN DEN BROECK W.: Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat.Histol. Embryol. 31, 214-223 (2002).
78. WALTNER-ROMEN M., FALKENSAMMER G., RABL W., WICK G.: A previously unrecognized site of local accumulation of mononuclear cells: the vascular-associated lymphoid tissue. J.Histochem.Cytochem. 46, 1347-1350 (1998).
79. WANG H., YANG H., CZURA C.J., SAMA A.E., TRACEY K.J.: HMOB1 as a late mediator of lethal systemic inflammation. Am.J.Respir. Crit.Care Med. 164, 1768-1773 (2001).
80. WICK G., PERSCHINKA H., MILLONIG G.: Atherosclerosis as an autoimmune disease: an update. Trends Immunol. 22, 665-669 (2001).
81. WICK G., KNOFLACH M., XU Q.: Autoimmune and inflammatory mechanisms in atherosclerosis. Ann.Rev.Immunol. 22, 361-403 (2004).